Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management: An Extension Study

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

March 5, 2024

Study Completion Date

March 5, 2024

Conditions

Fibromyalgia

Interventions

DEVICE

Digital ACT

Study participants will continue to receive Digital Acceptance and Commitment Therapy in addition to their standard care for fibromyalgia

Trial Locations (1)

Swing Therapeutics, San Francisco

All Listed Sponsors

lead

Swing Therapeutics, Inc.

OTHER